Topic outline

  • Grand Rounds

    We present a case of previously diagnosed chronic Central Serous Chorioretinopathy (CSCR) treated with PDT and verteporfin, with complete resolution of the Subretinal fluid (SRF). Fifteen years later the patient presented anew with decreased visual acuity in the same eye . Fundus examination showed new SRF and macular bleeding. SS-OCTA demonstrated Polypoidal Choroidal Vasculopathy (PCV) and Macular Neovascularization type 2. Following intravitreal injections of bevacizumab, the complete resolution of the SRF was achieved. After the treatment BCVA was 20/30. CSCR is the 4th most common retinopathy presenting with macular leakage, after Exudative Macular Degeneration, Diabetic Macular Edema, and Retinal Vascular Occlusions. PCV is a major cause of vision loss worldwide (Asians and Caucasians). Patient management requires an understanding of the natural history of PCV and its response to treatment. SS-OCTA is a convenient non-invasive strategy for identifying CSCR eyes with MNV without the need for dye-based angiography. SS-OCTA should become the new gold-standard for diagnosis and management of PCV.

    Presentation Date: 06/06/2024
    Issue Date: 06/28/2024